In Vitro Biosynthesis and Substrate Tolerance of the Plantazolicin Family of Natural Products
- 1 June 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 11 (8) , 2232-2243
Abstract
Plantazolicin (PZN) is a ribosomally synthesized and post-translationally modified peptide (RiPP) natural product that exhibits extraordinarily narrow-spectrum antibacterial activity toward the causative agent of anthrax, Bacillus anthracis. During PZN biosynthesis, a cyclodehydratase catalyzes cyclization of cysteine, serine, and threonine residues in the PZN precursor peptide (BamA) to azolines. Subsequently, a dehydrogenase oxidizes most of these azolines to thiazoles and (methyl)oxazoles. The final biosynthetic steps consist of leader peptide removal and dimethylation of the nascent N-terminus. Using a heterologously expressed and purified heterocycle synthetase, the BamA peptide was processed in vitro concordant with the pattern of post-translational modification found in the naturally occurring compound. Using a suite of BamA-derived peptides, including amino acid substitutions as well as contracted and expanded substrate variants, the substrate tolerance of the heterocycle synthetase was elucidated in vitro, and the residues crucial for leader peptide binding were identified. Despite increased promiscuity compared to what was previously observed during heterologous production in E. coli, the synthetase retained exquisite selectivity in cyclization of unnatural peptides only at positions which correspond to those cyclized in the natural product. A cleavage site was subsequently introduced to facilitate leader peptide removal, yielding mature PZN variants after enzymatic or chemical dimethylation. In addition, we report the isolation and characterization of two novel PZN-like natural products that were predicted from genome sequences but whose production had not yet been observed.Keywords
Funding Information
- NIH Office of the Director (DP2 OD008463)
- Division of Graduate Education (DGE-1144245)
- National Institute of General Medical Sciences (1R01 GM097142)
- University of Illinois at Urbana-Champaign
This publication has 60 references indexed in Scilit:
- Bacillus velezensis is not a later heterotypic synonym of Bacillus amyloliquefaciens; Bacillus methylotrophicus, Bacillus amyloliquefaciens subsp. plantarum and ‘Bacillus oryzicola’ are later heterotypic synonyms of Bacillus velezensis based on phylogenomicsInternational Journal of Systematic and Evolutionary Microbiology, 2016
- Natural Products as Sources of New Drugs from 1981 to 2014Journal of Natural Products, 2016
- The genomic landscape of ribosomal peptides containing thiazole and oxazole heterocyclesBMC Genomics, 2015
- Discovery of a new ATP-binding motif involved in peptidic azoline biosynthesisNature Chemical Biology, 2014
- Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclatureNatural Product Reports, 2012
- YcaO domains use ATP to activate amide backbones during peptide cyclodehydrationsNature Chemical Biology, 2012
- Structure Determination and Interception of Biosynthetic Intermediates for the Plantazolicin Class of Highly Discriminating AntibioticsACS Chemical Biology, 2011
- Plantazolicin A and B: Structure Elucidation of Ribosomally Synthesized Thiazole/Oxazole Peptides from Bacillus amyloliquefaciens FZB42Organic Letters, 2011
- Plantazolicin, a Novel Microcin B17/Streptolysin S-Like Natural Product from Bacillus amyloliquefaciens FZB42Journal of Bacteriology, 2011
- Discovery of a widely distributed toxin biosynthetic gene clusterProceedings of the National Academy of Sciences, 2008